Primary information |
---|
sequence ID | Seq_9779 |
Peptide sequence | YLQGAKIPKPEASFSPR |
CancerPDF_ID | CancerPDF_ID1858, CancerPDF_ID12732, |
PMID | 21136997,27058005 |
Protein Name | Inter-alpha-trypsin inhibitor heavy chain H4,Inter-alpha-trypsin inhibitor heavy chain H5 |
UniprotKB Entry Name | ITIH4_HUMAN,ITIH5_HUMAN |
Fluid | Serum,Serum |
M/Z | 1888.02068,1889.031 |
Charge | 1,NA |
Mass (in Da) | NA,NA |
fdr | NA,NA |
Profiling Technique | LC-MS,MALDI-TOF |
Peptide Identification technique | LC-MS-MS/MS,LC-MS/MS |
Quantification Technique | LC-ESI-MS,NA |
Labelled/Label Free | Label Free,Label Free |
FDR | NA,NA |
CancerPDF_ID | CancerPDF_ID1858, CancerPDF_ID12732, |
p-Value | NA,"0.338,0.473,less than 0.01" |
Software | MASCOT(v. 2.2.01),Proteome Discoverer |
Length | 17,17 |
Cancer Type | Colorectal cancer,Breast cancer |
Database | SwissProt Database,SwissProt Database |
Modification | NA,NA |
Number of Patients | 30 patients and 30 healthy controls," 28 were diagnosed with Breast cancer, 27 remained cancer-free with BRCA carrier. Of the remaining patients, 39 were diagnosed with sporadic breast cancer (SBC), and 38 were healthy volunteers (WT)." |
Regulation | NA,"Upregulated with the fold change of 1.14 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.08, Upregulated in BC vs healthy with 1.244 fold change" |
Validation | Leave One out Cross validation,NA |
Sensitivity | NA,NA |
Specificity | NA,NA |
Accuracy | NA,NA |
Peptide Atlas | NA |
IEDB | |